Search Results for: moderna

Pfizer/BioNTech and Moderna will increase the production of COVID-19 vaccines

Pfizer/BioNTech and Moderna will increase the production of COVID-19 vaccines

Thanks to the adoption by the Committee for Medicines for Human (CHMP) belonging to the European Medicines Agency (EMA), two recommendations in April 2021 will increase the production capacity and supply of each of the companies producing vaccines against COVID-19. We are talking about the Pfizer/BioNTech and Moderna. Acceleration of production and a new production…

Moderna: COVID-19 vaccine effective at 94.5%

Moderna: COVID-19 vaccine effective at 94.5%

Another company has announced success in clinical trials. This is about a product developed by Moderna. The vaccine in the third phase of clinical trials showed 94.5% effectiveness. The company wants to apply for an accelerated market authorisation. Scientific battle for victory with COVID-19 The race for the groundbreaking discovery of an effective preparation for…

COVID-19 vaccine: the third dose for everyone ?
| | |

COVID-19 vaccine: the third dose for everyone ?

On November 2, registration for the COVID-19 booster vaccination for adults began, provided it has been at least six months since receiving the full vaccination. As of mid-September, only people over the age of 50, medical personnel in contact with patients, and people who are immunocompromised could make appointments for the booster vaccination. The booster shot…

Samsung announced $205bn investment plan

Samsung announced $205bn investment plan

By 2023, Samsung will invest as much as $205bn in its pharmaceutical, biopharmaceutical, semiconductor and telecommunications industries. This investment is intended to support the company’s further growth and biosimilar drug production ventures by Samsung Bioepis and its Samsung Biologic contract manufacturing unit, which recently began producing Moderna’s COVID-19 vaccine. The company’s activities are aimed at…

Paid vaccinations for COVID-19 in the autumn?

Paid vaccinations for COVID-19 in the autumn?

The idea is controversial, but there are many indications that such a scenario is feasible. There are also many voices claiming that the government wants to encourage people delaying the COVID-19 vaccination to get vaccinated as soon as possible. This is because currently 16.97 million people in Poland have been vaccinated, 80% of whom are…

Pharmaceutical companies invest in Poland
|

Pharmaceutical companies invest in Poland

Bayer has announced plans to launch its Digital Hub in Poland. The unit is to be launched in July this year and will be responsible for designing digital solutions for the pharmaceutical and agricultural industries. Another pharmaceutical company, Moderna, is also planning to invest in our country. Bayer opens Digital Hub in Poland At the…

Is the end of the COVID-19 pandemic possible in five months’ time?

Is the end of the COVID-19 pandemic possible in five months’ time?

According to the announcement, by the end of August, every willing Polish citizen is to receive the vaccination for COVID-19. In the second half of April, the vaccine for COVID-19 of the fourth company – Johnson & Johnson (J&J) – will come to Poland. This is to greatly facilitate the implementation of the National Vaccination…

Pfizer tests the world’s first anti COVID-19 pill
|

Pfizer tests the world’s first anti COVID-19 pill

Pfizer is launching a phase 1 trial of a new oral antiviral drug against SARS-COV-2. The drug for COVID-19 in a tablet, named PF-07321332, was developed in the US. Candidate for an effective drug to prevent COVID-19 Pfizer, which launched the first approved COVID-19 vaccine in the US, is now conducting a clinical trial of…

Poland to resell vaccines against COVID-19
|

Poland to resell vaccines against COVID-19

Deputy Health Minister Maciej Miłkowski said that Poland will resell 4 million of the 20 million vaccines purchased from AstraZeneca. The vaccines are to be resold to countries outside the European Union (EU).   Poland buys 20 million doses of AstraZeneca vaccines Deputy Health Minister Maciej Miłkowski announced that Poland will resell 4 million of…

MSD: Dimitri Gitas from Greece to Poland

MSD: Dimitri Gitas from Greece to Poland

Dimitri Gitas has been appointed Managing Director of the Polish branch of biopharmaceutical company MSD Poland as of 1 February 2021. MSD is known as Merck in the United States and Canada. Dimitri Gitas has a degree in biochemistry from the University of Ottawa and has been involved in the pharmaceutical industry for many years….